OtsukaLtd. 

$76.10
89
+$0.00+0% Wednesday 20:00

Statistics

Day High
76.1
Day Low
76.1
52W High
79
52W Low
44.4
Volume
100
Avg. Volume
66
Mkt Cap
41.32B
P/E Ratio
15.57
Dividend Yield
0.82%
Dividend
0.62

Upcoming

Dividends

0.82%Dividend Yield
Sep 26
$0.62
Mar 26
$0.44
Sep 25
$0.48
Mar 25
$0.40
Sep 24
$0.41
10Y Growth
1.36%
5Y Growth
3.23%
3Y Growth
13.97%
1Y Growth
21.3%

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.78
1.11
1.45
1.78
Expected EPS
1.119711638378
Actual EPS
N/A

Financials

14.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
16.96BRevenue
2.51BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OTSKF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Otsuka in various therapeutic areas, including psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment, competes directly with Otsuka in the development and marketing of drugs for various conditions.
Novartis
NVS
Mkt Cap292.35B
Novartis is a leading healthcare company that competes with Otsuka in several areas, including neuroscience and digital health solutions.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes with Otsuka in the pharmaceutical sector, particularly in the development of medications for psychiatric conditions.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes with Otsuka in the neuroscience domain, particularly in the development of treatments for psychiatric disorders.
Merck
MRK
Mkt Cap366B
Merck & Co. competes with Otsuka in the healthcare sector, focusing on pharmaceuticals that address critical areas of health.
Takeda Pharmaceutical
TAK
Mkt Cap57.58B
Takeda Pharmaceutical Company competes with Otsuka, especially in Japan and in the field of neuroscience, sharing a similar market focus.
Rogers
ROG
Mkt Cap2.24B
Roche Holding AG competes with Otsuka in the pharmaceutical and diagnostics sectors, particularly in areas like personalized healthcare.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes with Otsuka in various therapeutic areas, including the development of treatments for diseases in oncology and cardiovascular.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb competes with Otsuka in the pharmaceutical sector, particularly in the development of innovative medicines for serious diseases.

About

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Show more...
CEO
Makoto Inoue
Employees
37758
Country
Japan
ISIN
JP3188220002
WKN
000A1C9KC

Listings

0 Comments

Share your thoughts

FAQ

What is OtsukaLtd. stock price today?
The current price of OTSKF is $76.10 USD — it has increased by +0% in the past 24 hours. Watch OtsukaLtd. stock price performance more closely on the chart.
What is OtsukaLtd. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange OtsukaLtd. stocks are traded under the ticker OTSKF.
What is OtsukaLtd. market cap?
Today OtsukaLtd. has the market capitalization of 41.32B
When is the next OtsukaLtd. earnings date?
OtsukaLtd. is going to release the next earnings report on November 04, 2026.
What were OtsukaLtd. earnings last quarter?
OTSKF earnings for the last quarter are 1.37 USD per share, whereas the estimation was 1.01 USD resulting in a +35.9% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is OtsukaLtd. revenue for the last year?
OtsukaLtd. revenue for the last year amounts to 16.96B USD.
What is OtsukaLtd. net income for the last year?
OTSKF net income for the last year is 2.51B USD.
Does OtsukaLtd. pay dividends?
Yes, OTSKF dividends are paid semi-annual. The last dividend per share was 0.62 USD. As of today, Dividend Yield (FWD)% is 0.82%.
How many employees does OtsukaLtd. have?
As of September 04, 2026, the company has 37,758 employees.
In which sector is OtsukaLtd. located?
OtsukaLtd. operates in the Health & Wellness sector.
When did OtsukaLtd. complete a stock split?
OtsukaLtd. has not had any recent stock splits.
Where is OtsukaLtd. headquartered?
OtsukaLtd. is headquartered in Tokyo, Japan.